North America Drug Screening Market Share

ID: MRFR/LS/0978-HCR

50 Pages

Rahul Gotadki

October 2025

North America Drug Screening Market - by Test Sample (Urine, Blood, Hair and Saliva) by condition (Unconsciousness, Panic Attack, Chest Pain, Drug Allergies and Others)- Forecast to 2035

North America Drug Screening Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Share

North America Drug Screening Market Share Analysis

The drug screening market is a dynamic and evolving industry that plays a crucial role in ensuring workplace safety, compliance with regulations, and public health. As companies and organizations prioritize substance abuse prevention, the competition within the drug screening market intensifies, prompting businesses to adopt effective market share positioning strategies. Market share positioning determines the company’s place in relation to its competitors. The drug screening industry sees companies adopting several strategies to increase their market share with a goal of capturing more customers who will also translate into higher revenue. What seems to be a critical strategy for companies in the drug screening market includes remaining at the cutting edge of technology. Continuous innovation in testing systems, tools and software do not only attract new customers but also retained existing ones. Fast response to breakthrough technologies like enhanced methods of detection, and instant testing policies can differentiate a company from the competition. Competent market guys working in the field of drug screening understand that it is crucial to provide a wide selection of testing services. This covers the urine, saliva hair follicle and blood tests to enable them meet diverse demands of other industries and regulatory needs. Diversification does not only increase the customer base but also increases market robustness of a company. Geographical extension is a key strategy for achieving wider market share. Companies forge strategic alliances, partnerships or acquisitions to gain access into new markets and strengthen their position in the other ones. Agreements with health care providers, laboratories and regulators make up a complete established market position. In consideration of the stringent rules that govern drug testing, compliance standards are an integral part and non-negotiable factor in market share positioning. Through rigorous quality assurance, certifications and compliance to industry guidelines helps companies in developing a reputation for reliability as well as trustworthiness that are important factors to capture market share. In order to capitalize on the specific requirements of their clients, companies that have been successful in this drug screening market pay much attention to customization. Customization of their solutions to different industries’ requirements, regulatory environments and company policies guarantees customer satisfaction. A client-focused strategy enables the company to secure loyalty and positive reputation, which leads it towards market leadership. In a market with competition, price is key. Companies that provide affordable solutions without compromising on quality enjoy a competitive advantage. Besides, creating a good value proposition like quick turnaround times and quality analysis with superior customer service increases the attractiveness of an organization in terms of winning new customers. The marketing strategy is vital for the market share positioning because it helps build a strong brand presence. Companies invest in creating awareness, highlighting their unique selling points, and establishing themselves as industry leaders. A robust online presence, participation in industry events, and targeted advertising contribute to a compelling brand image. As the drug screening industry is in a constant state of change, on-going training and education are essential. The companies that invest in training their staff and providing education materials to its clients are a niche of experts. This not only increases credibility, but it also boosts confidence among customers in regards to the effectiveness of their products and services.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the North America drug screening market Size was estimated at 1200.0 USD Million in 2024. The North America drug screening market is projected to grow from 1245.0 USD Million in 2025 to 1800.0 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 3.75% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The North America drug screening market is experiencing robust growth driven by technological advancements and increasing regulatory compliance.

Technological advancements are enhancing the accuracy and efficiency of drug screening processes across the region.
The US remains the largest market for drug screening, while Canada is emerging as the fastest-growing region in this sector.
There is a notable shift towards preventive healthcare, with an increasing emphasis on early detection and intervention.
Key market drivers include rising substance abuse rates and stringent workplace safety regulations, which are propelling the demand for comprehensive drug testing solutions.

North America Drug Screening Market

CAGR

3.75%

Market Size & Forecast

2024 Market Size	1200.0 (USD Million)
2035 Market Size	1800.0 (USD Million)
CAGR (2025 - 2035)	3.75%

Major Players

Thermo Fisher Scientific (US), Abbott Laboratories (US), Roche Diagnostics (CH), Siemens Healthineers (DE), Quest Diagnostics (US), Alere Inc. (US), LabCorp (US), Bio-Rad Laboratories (US), Medtox Scientific (US)

Market Trends

The drug screening market in North America is currently experiencing notable growth, driven by increasing awareness regarding substance abuse and the need for effective monitoring solutions. Regulatory bodies are emphasizing the importance of drug testing in various sectors, including healthcare, law enforcement, and employment. This heightened focus on compliance and safety is likely to propel the demand for advanced drug screening technologies. Furthermore, the integration of innovative methodologies, such as oral fluid testing and rapid testing kits, appears to enhance the efficiency and accuracy of drug detection processes. As a result, stakeholders in the drug screening market are adapting to these evolving needs by investing in research and development to improve product offerings. In addition, the rise of personalized medicine and the growing acceptance of drug screening in clinical settings suggest a shift towards more comprehensive testing solutions. The market is likely to benefit from advancements in technology, including automation and digitalization, which may streamline testing procedures and reduce turnaround times. Moreover, the increasing prevalence of substance use disorders in North America necessitates a proactive approach to drug screening, further solidifying its role in public health initiatives. Overall, the drug screening market is poised for continued expansion as it aligns with the broader trends of health and safety in society.

Technological Advancements

The drug screening market is witnessing a surge in technological innovations, particularly in testing methodologies. Newer techniques, such as point-of-care testing and mobile applications, are enhancing the accessibility and efficiency of drug detection. These advancements are likely to improve user experience and accuracy, making drug screening more reliable.

Regulatory Compliance

There is an increasing emphasis on regulatory compliance within the drug screening market. Organizations are adopting stringent testing protocols to meet legal requirements and ensure workplace safety. This trend is expected to drive demand for comprehensive drug testing solutions across various industries.

Focus on Preventive Healthcare

The drug screening market is aligning with the broader trend of preventive healthcare. As awareness of substance abuse issues grows, there is a shift towards proactive screening measures. This focus on early detection and intervention is likely to enhance the role of drug screening in public health strategies.

North America Drug Screening Market Market Drivers

Workplace Safety Regulations

The enforcement of stringent workplace safety regulations is a key driver of the drug screening market. Regulatory bodies in North America are increasingly mandating drug testing as part of occupational health and safety protocols. This trend is particularly evident in industries such as transportation, construction, and manufacturing, where safety is paramount. Companies are investing in drug screening programs to comply with these regulations and to protect their workforce. The market is likely to expand as organizations recognize the importance of maintaining a drug-free workplace. Furthermore, the potential financial implications of workplace accidents related to substance abuse are prompting employers to prioritize drug testing, thereby contributing to the growth of the drug screening market.

Increasing Substance Abuse Rates

The rising rates of substance abuse in North America are driving the drug screening market. According to the Substance Abuse and Mental Health Services Administration, approximately 20.3 million individuals aged 12 or older had a substance use disorder in 2020. This alarming trend necessitates the implementation of drug screening programs across various sectors, including workplaces and educational institutions. Employers are increasingly adopting drug testing policies to ensure a safe and productive work environment. The drug screening market is likely to see a surge in demand for testing kits and services as organizations strive to mitigate risks associated with substance abuse. Furthermore, the growing awareness of the health implications of drug use is prompting more individuals to seek screening, thereby expanding the market's reach and potential.

Rising Demand for Home Testing Kits

The growing consumer preference for home testing solutions is reshaping the drug screening market. Individuals are increasingly seeking convenient and private options for drug testing, leading to a surge in demand for home testing kits. These kits offer users the ability to conduct tests in the comfort of their own homes, which is particularly appealing in a society that values privacy and convenience. Market analysts suggest that the home drug testing segment could witness a growth rate of approximately 15% in the coming years. This shift is also influenced by the increasing awareness of drug-related issues and the desire for proactive health management. As a result, manufacturers are focusing on developing user-friendly and reliable home testing products to cater to this emerging demand.

Technological Innovations in Testing

Technological advancements in drug testing methodologies are significantly influencing the drug screening market. Innovations such as rapid testing devices and point-of-care testing solutions are enhancing the efficiency and accuracy of drug screening processes. For instance, the introduction of oral fluid testing has gained traction due to its non-invasive nature and quick results. The market for drug screening is projected to grow as these technologies become more widely adopted, with estimates suggesting a compound annual growth rate (CAGR) of around 10% over the next few years. Additionally, the integration of artificial intelligence and machine learning in data analysis is expected to improve the interpretation of test results, further driving the demand for advanced drug screening solutions in North America.

Expansion of Drug Screening in Healthcare

The integration of drug screening into healthcare practices is becoming increasingly prevalent, thereby impacting the drug screening market. Healthcare providers are recognizing the importance of drug testing in managing patient care, particularly in addiction treatment and pain management. The implementation of routine drug screenings can help identify substance abuse issues early, allowing for timely intervention. This trend is supported by the growing emphasis on preventive healthcare measures, which aim to improve overall patient outcomes. The drug screening market is expected to benefit from this expansion, with healthcare facilities investing in comprehensive drug testing programs. As the healthcare sector continues to evolve, the demand for reliable and accurate drug screening solutions is likely to increase, further driving market growth.

Market Segment Insights

By Type: Urine Testing (Largest) vs. Saliva Testing (Fastest-Growing)

In the drug screening market, urine testing remains the dominant method, holding the largest market share due to its reliability and established protocols. This method is widely accepted in various settings, such as workplaces and legal scenarios, reinforcing its position as the preferred choice among testing options. Saliva testing, while smaller in market share, is rapidly gaining attention because of its non-invasive nature and convenience, appealing particularly to an increasingly health-conscious public. The growth of saliva testing can be attributed to advancements in technology and increased awareness about the benefits of using non-invasive methods. As regulations evolve and the drug testing landscape shifts, the demand for saliva testing is expected to rise, making it the fastest-growing segment in this market. With greater flexibility and ease of use, saliva testing is poised to capture a larger share of the market over time, challenging traditional methods like urine testing.

Urine Testing (Dominant) vs. Hair Testing (Emerging)

Urine testing is recognized as the dominant method in the drug screening market due to its high sensitivity and comprehensive detection capabilities, which make it suitable for a wide array of substances. It has established protocols that ensure reliability and is preferred in both employment and legal drug testing scenarios. Conversely, hair testing has emerged as a notable alternative, particularly for long-term detection of drug use. While it currently holds a smaller share in the market, hair testing is gaining traction among employers and rehabilitation programs as it offers a longer detection window, providing insights into historical drug use patterns. As awareness grows, the hair testing segment is likely to expand, appealing to those requiring detailed drug testing results.

By Technology: Mass Spectrometry (Largest) vs. Immunoassay (Fastest-Growing)

In the drug screening market, Mass Spectrometry holds the largest market share, primarily due to its high accuracy and ability to detect a wide range of substances. This technology is widely adopted in clinical laboratories and forensic applications, contributing significantly to its market dominance. In contrast, Immunoassay is gaining traction as the fastest-growing segment due to its rapid testing capabilities and user-friendly nature, making it popular for point-of-care testing settings. Growth trends indicate a strong demand for advanced drug screening technologies driven by increasing substance abuse cases and stringent regulations regarding drug testing. The adoption of Mass Spectrometry is propelled by its effectiveness in forensic and clinical settings, while Immunoassay benefits from innovations in rapid testing and automation, enhancing efficiency in drug screening processes.

Technology: Mass Spectrometry (Dominant) vs. Immunoassay (Emerging)

Mass Spectrometry is characterized by its unmatched sensitivity and specificity, allowing for comprehensive drug profiling and confirmation analyses. It excels in various applications, including toxicology and clinical testing, solidifying its position as a dominant force in the market. Conversely, Immunoassay technology is emerging rapidly due to its cost-effectiveness and ease of use, making it suitable for widespread implementation in non-laboratory settings, such as workplaces and clinics. Its ability to deliver quick results for initial screenings positions Immunoassay as a key player in addressing the growing need for immediate drug testing solutions.

By End Use: Workplace (Largest) vs. Drug Rehabilitation Centers (Fastest-Growing)

In the North America drug screening market, the 'End Use' segment is led by the Workplace category, which commands a significant market share. It is the primary sector driving demand for drug screening solutions, followed by Drug Rehabilitation Centers, Hospitals and Clinics, and Law Enforcement. Each of these segments plays a crucial role, but Workplace stands out as the most substantial contributor to overall market dynamics due to stringent employer policies on substance use and the necessity for maintaining a safe, productive working environment. Growth trends indicate that Drug Rehabilitation Centers are emerging as the fastest-growing segment in this market. This is driven by increasing awareness of substance abuse issues and the need for effective monitoring solutions to support recovery efforts. Additionally, advancements in screening technologies and rising government initiatives to tackle drug-related problems are further propelling the demand in these facilities. Overall, the dynamics within the 'End Use' segment reflect a crucial intersection of regulatory frameworks, social awareness, and technological innovations.

Workplace: Dominant vs. Drug Rehabilitation Centers: Emerging

The Workplace segment remains dominant in the North America drug screening market due to its essential role in ensuring a safe and efficient work environment. Employers are increasingly adopting rigorous drug screening protocols as part of their health and safety policies, which significantly heightens market demand. Conversely, Drug Rehabilitation Centers are deemed an emerging segment, reflecting a rising trend in addressing substance abuse through recovery programs. These centers are integrating advanced drug testing methodologies to enhance their therapeutic efficacy, thus adapting to the evolving landscape of addiction treatment. The synergy of societal needs and healthcare practices positions both segments strategically within the market, demonstrating the complexity and interdependence of end-use applications.

By Panel Size: Multi-Panel (Largest) vs. Expanded Panel (Fastest-Growing)

The market share distribution among the panel size segment reveals that Multi-Panel tests command the largest share, being the preferred choice for many organizations due to their ability to screen for multiple substances at once. In contrast, Single Panel tests are gradually losing traction as they offer limited functionality, while Expanded Panels are gaining popularity for their comprehensive screening capabilities across a wider range of substances. Growth trends indicate a significant shift towards Expanded Panels, as companies and healthcare providers recognize the need for more thorough testing to address the evolving landscape of substance abuse. Drivers of this growth include increased awareness of drug-related issues, advancements in testing technologies, and the growing preference for multifunctional solutions in drug testing protocols.

Multi-Panel (Dominant) vs. Expanded Panel (Emerging)

The Multi-Panel segment has established itself as the dominant force in the market, primarily due to its efficiency in identifying multiple drugs simultaneously with minimal time and effort. This efficiency appeals to workplaces, law enforcement, and healthcare settings that require timely results. On the other hand, the Expanded Panel segment represents an emerging trend, providing in-depth screening capabilities that cater to the complex requirements of modern drug testing. As regulatory bodies emphasize the necessity for comprehensive testing, Expanded Panels are anticipated to carve a more significant niche, capturing the attention of stakeholders eager for detailed insight into substance use patterns.

Get more detailed insights about North America Drug Screening Market Research Report- North America Forecast to 2035

Regional Insights

US : Leading Market with Robust Growth

The US drug screening market is valued at $1000.0 million, representing a significant share of the North American market. Key growth drivers include increasing substance abuse awareness, stringent regulatory frameworks, and advancements in testing technologies. Demand trends show a rising preference for rapid testing solutions, supported by government initiatives aimed at enhancing workplace safety and public health. Infrastructure improvements in healthcare facilities further bolster market growth.

Canada : Expanding Opportunities in Drug Testing

Canada's drug screening market is valued at $200.0 million, accounting for a smaller yet growing segment of the North American landscape. Key growth drivers include rising awareness of drug-related issues and supportive government policies promoting health and safety. Demand is increasing for both workplace and clinical testing, with a focus on innovative testing methods. Regulatory frameworks are evolving to accommodate new technologies, enhancing market potential.

Key Players and Competitive Insights

The drug screening market in North America is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and technological advancements. Key players such as Thermo Fisher Scientific (US), Abbott Laboratories (US), and Quest Diagnostics (US) are at the forefront, leveraging their extensive portfolios and R&D capabilities to enhance their market positions. These companies appear to focus on developing advanced testing solutions that cater to a growing demand for rapid and accurate drug screening, driven by regulatory requirements and the rising prevalence of substance abuse. Their collective strategies suggest a trend towards integrated solutions that combine testing with data analytics, thereby enhancing operational efficiency and customer engagement.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to respond swiftly to market demands. The competitive structure of the market seems moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set benchmarks for quality and innovation. This dynamic fosters a competitive environment where smaller firms must innovate or collaborate to remain relevant, indicating a potential shift towards consolidation in the future.

In October 2025, Thermo Fisher Scientific (US) announced the launch of a new line of rapid drug testing kits designed for workplace screening. This strategic move is likely to enhance their market share by addressing the urgent need for quick and reliable testing solutions in corporate environments. The introduction of these kits not only aligns with current trends towards workplace safety but also positions Thermo Fisher as a leader in the rapid testing segment, potentially increasing their revenue streams significantly.

In September 2025, Abbott Laboratories (US) expanded its partnership with a leading telehealth provider to integrate drug screening services into virtual healthcare platforms. This initiative appears to be a strategic response to the growing demand for remote healthcare solutions, particularly in drug screening. By embedding their testing capabilities within telehealth services, Abbott is likely to enhance accessibility and convenience for patients, thereby capturing a broader market segment and reinforcing its competitive edge.

In August 2025, Quest Diagnostics (US) launched a new AI-driven analytics platform aimed at improving the accuracy and efficiency of drug screening processes. This development suggests a significant shift towards digital transformation within the industry, as AI technologies are increasingly recognized for their potential to streamline operations and enhance decision-making. By adopting such advanced technologies, Quest Diagnostics may not only improve its service offerings but also set a new standard for operational excellence in drug screening.

As of November 2025, the competitive trends in the drug screening market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing their service offerings and expanding their market reach. Looking ahead, it appears that competitive differentiation will increasingly hinge on innovation and technological advancements rather than solely on price. Companies that prioritize R&D and supply chain reliability are likely to emerge as leaders in this evolving landscape.

Key Companies in the North America Drug Screening Market market include

Industry Developments

Future Outlook

North America Drug Screening Market Future Outlook

The drug screening market is projected to grow at a 3.75% CAGR from 2024 to 2035, driven by technological advancements, regulatory changes, and increasing demand for workplace safety.

New opportunities lie in:

Development of mobile drug testing units for remote locations.
Integration of AI-driven analytics for real-time screening results.
Expansion of subscription-based testing services for businesses.

By 2035, the market is expected to achieve robust growth, reflecting evolving industry needs.

Market Segmentation

North America Drug Screening Market Type Outlook

Urine Testing
Saliva Testing
Blood Testing
Hair Testing

North America Drug Screening Market End Use Outlook

Workplace
Drug Rehabilitation Centers
Hospitals and Clinics
Law Enforcement

North America Drug Screening Market Panel Size Outlook

Single Panel
Multi-Panel
Expanded Panel

North America Drug Screening Market Technology Outlook

Immunoassay
Chromatography
Mass Spectrometry
PCR Testing

Report Scope

MARKET SIZE 2024	1200.0(USD Million)
MARKET SIZE 2025	1245.0(USD Million)
MARKET SIZE 2035	1800.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	3.75% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Million
Key Companies Profiled	["Thermo Fisher Scientific (US)", "Abbott Laboratories (US)", "Roche Diagnostics (CH)", "Siemens Healthineers (DE)", "Quest Diagnostics (US)", "Alere Inc. (US)", "LabCorp (US)", "Bio-Rad Laboratories (US)", "Medtox Scientific (US)"]
Segments Covered	Type, Technology, End Use, Panel Size
Key Market Opportunities	Integration of advanced technologies enhances efficiency in the drug screening market.
Key Market Dynamics	Regulatory changes and technological advancements drive innovation in the North American drug screening market.
Countries Covered	US, Canada

FAQs

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. EXECUTIVE SUMMARY
  1. Market Overview
  2. Key Findings
  3. Market Segmentation
  4. Competitive Landscape
  5. Challenges and Opportunities
  6. Future Outlook
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. MARKET INTRODUCTION
  1. Definition
  2. Scope of the study
2. RESEARCH METHODOLOGY
  1. Overview
  2. Data Mining
  3. Secondary Research
  4. Primary Research
  5. Forecasting Model
  6. Market Size Estimation
  7. Data Triangulation
  8. Validation
SECTION III: QUALITATIVE ANALYSIS
1. MARKET DYNAMICS
  1. Overview
  2. Drivers
  3. Restraints
  4. Opportunities
2. MARKET FACTOR ANALYSIS
  1. Value chain Analysis
  2. Porter's Five Forces Analysis
  3. COVID-19 Impact Analysis
SECTION IV: QUANTITATIVE ANALYSIS
1. Chemicals and Materials, BY Type (USD Million)
  1. Urine Testing
  2. Saliva Testing
  3. Blood Testing
  4. Hair Testing
2. Chemicals and Materials, BY Technology (USD Million)
  1. Immunoassay
  2. Chromatography
  3. Mass Spectrometry
  4. PCR Testing
3. Chemicals and Materials, BY End Use (USD Million)
  1. Workplace
  2. Drug Rehabilitation Centers
  3. Hospitals and Clinics
  4. Law Enforcement
4. Chemicals and Materials, BY Panel Size (USD Million)
  1. Single Panel
  2. Multi-Panel
  3. Expanded Panel
SECTION V: COMPETITIVE ANALYSIS
1. Competitive Landscape
  1. Overview
  2. Competitive Analysis
  3. Market share Analysis
  4. Major Growth Strategy in the Chemicals and Materials
  5. Competitive Benchmarking
  6. Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. Key developments and growth strategies
  8. Major Players Financial Matrix
2. Company Profiles
  1. Thermo Fisher Scientific (US)
  2. Abbott Laboratories (US)
  3. Roche Diagnostics (CH)
  4. Siemens Healthineers (DE)
  5. Quest Diagnostics (US)
  6. Alere Inc. (US)
  7. LabCorp (US)
  8. Bio-Rad Laboratories (US)
  9. Medtox Scientific (US)
3. Appendix
  1. References
  2. Related Reports
LIST OF FIGURES
1. MARKET SYNOPSIS
2. NORTH AMERICA MARKET ANALYSIS BY TYPE
3. NORTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
4. NORTH AMERICA MARKET ANALYSIS BY END USE
5. NORTH AMERICA MARKET ANALYSIS BY PANEL SIZE
6. KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. RESEARCH PROCESS OF MRFR
8. DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
13. CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
14. CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
15. CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
17. CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
18. CHEMICALS AND MATERIALS, BY PANEL SIZE, 2024 (% SHARE)
19. CHEMICALS AND MATERIALS, BY PANEL SIZE, 2024 TO 2035 (USD Million)
20. BENCHMARKING OF MAJOR COMPETITORS
LIST OF TABLES
1. LIST OF ASSUMPTIONS
2. North America MARKET SIZE ESTIMATES; FORECAST
  1. BY TYPE, 2025-2035 (USD Million)
  2. BY TECHNOLOGY, 2025-2035 (USD Million)
  3. BY END USE, 2025-2035 (USD Million)
  4. BY PANEL SIZE, 2025-2035 (USD Million)
3. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
4. ACQUISITION/PARTNERSHIP

North America Chemicals and Materials Market Segmentation

Chemicals and Materials By Type (USD Million, 2025-2035)

Urine Testing
Saliva Testing
Blood Testing
Hair Testing

Chemicals and Materials By Technology (USD Million, 2025-2035)

Immunoassay
Chromatography
Mass Spectrometry
PCR Testing

Chemicals and Materials By End Use (USD Million, 2025-2035)

Workplace
Drug Rehabilitation Centers
Hospitals and Clinics
Law Enforcement

Chemicals and Materials By Panel Size (USD Million, 2025-2035)

Single Panel
Multi-Panel
Expanded Panel

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓